Table 3. Distribution of selected CRISPRs across body sites.
| Oral | Skin | |||||||
| CRISPR | Anterior nares (94a) | Stool (148) | Buccal mucosa (121) | Supra-gingival plaque (128) | Tongue dorsum (135) | Posterior fornix (61) | L- (9)c | R- (18)d |
| SmutaL36 | 11b | 4 | 97 | 120 | 128 | 0 | 0 | 1 |
| AhydrL30 | 0 | 53 | 0 | 0 | 0 | 0 | 0 | 0 |
| BcoprL32 | 0 | 65 | 0 | 0 | 0 | 0 | 0 | 0 |
| FalocL36 | 0 | 63 | 1 | 18 | 50 | 0 | 0 | 0 |
| Neis_t014_L28 | 0 | 51 | 15 | 58 | 15 | 0 | 0 | 0 |
| Neis_t014_L36 | 0 | 0 | 37 | 66 | 82 | 0 | 0 | 0 |
| PacneL29 | 1 | 0 | 0 | 0 | 0 | 0 | 4 | 7 |
a
the total number of datasets;
b
the total number of datasets that have CRISPRs identified;
c
L-Retroauricular crease;
d
R-Retroauricular crease. Note not all body sites are listed in this table.